Dopamine agonists, sleep disorders, and driving in Parkinson's disease

Adv Neurol. 2003:91:343-9.

Authors

Ryan J Uitti¹, Zbigniew K Wszolek

Affiliation

¹ Department of Neurology, Mayo Clinic Jacksonville, Jacksonville, Florida, USA.

PMID: 12442692

No abstract available

Publication types

Review

MeSH terms

Accidents, Traffic / prevention & control
Antiparkinson Agents / adverse effects*
Brain / drug effects
Brain / pathology
Brain / physiopathology
Dopamine Agonists / adverse effects*
Humans
Neural Pathways / drug effects
Neural Pathways / pathology
Neural Pathways / physiopathology
Parkinson Disease / drug therapy*
Receptors, Dopamine / drug effects
Receptors, Dopamine / metabolism
Sleep Deprivation / chemically induced
Sleep Deprivation / physiopathology
Sleep Wake Disorders / chemically induced*
Sleep Wake Disorders / pathology
Sleep Wake Disorders / physiopathology

Substances

Antiparkinson Agents
Dopamine Agonists
Receptors, Dopamine